Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

Cannabis Law Report

MAY 29, 2022

And there are literally hundreds of trials that are being done, and more forthcoming.”. Ciprick said there needs to be more outcome data and studies on the psilocybin-producing mushrooms to give that comfort level heading forward into introducing a larger market for the product. I’m excited that we pulled our first crop down.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Key Responsibilities.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

JULY 4, 2019

The manuscript is part of EMMAC’s collaboration with Imperial College London, forged to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. About EMMAC.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

FEBRUARY 2, 2022

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). This application comes on the heels of Colombia’s new legislation requiring insurance companies to cover cannabis prescriptions. “I About Flora Growth Corp.

Cannabinoids 52

Cannabinoids Clinical Trials Events Cultivation 52

Cannabis Law Report

JANUARY 6, 2022

Tim Leslie brings significant experience in both the cannabis industry and international growth and business development, including an extensive career at Amazon, to the organization. Since his time there, Leslie has served on the board of renowned cannabis companies before his appointment as Chairman of the Board of Advisors at Flora. “I

Research and Development 52

Research and Development Events Clinical Trials Business 52

Cannabis Law Report

AUGUST 3, 2021

Having spent the last calendar year putting into place the constituent components for a high-throughput clinical laboratory for COVID-19 testing, this award is a significant milestone for the Company’s Diagnostics business,” stated Dr. James A. Hayward, president and CEO of Applied DNA. Visit adnas.com for more information.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

AUGUST 18, 2022

As research into the use of psychedelic therapies continues to expand and additional data demonstrate significant positive outcomes in the treatment of mental health conditions, the benefits that psychedelics offer will continue to gain acceptance and understanding across the medical community. . ” Joining Ms.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Deputy General Counsel Executive Summary.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

JUNE 2, 2021

Key end-markets include Gov/Mil, textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. Visit adnas.com for more information. Join our mailing list.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

The Blunt Truth

AUGUST 13, 2019

CBD is “thriving” in the current regulatory environment, but is it doing so illegally? To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps. As former U.S.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

The Cannigma

JUNE 15, 2021

Like all plants, cannabis contains a plethora of molecules, some of which have specific functions — such as determining the smell, taste and color of the plant, but also what types of effects it can have on you. This is why eating raw cannabis won’t necessarily get you high — it is full of non-decarboxylated THCA. CBD vs THC.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. Advancements in IP and Drug Development.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JUNE 1, 2021

Director of Medical Affairs and a Product Development Team lead at Greenwich Biosciences, where he played an important role in the complex, successful commercialization of the first cannabis-based product approved by the FDA to treat rare forms of epilepsy. For more information, please visit the Company’s website at www.sesenbio.com.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Since the early 1990s, Israel has stood at the front line of cannabis medicalization.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JUNE 3, 2022

Draft, review, and evaluate complex commercial, corporate, and intellectual property transactions, including license, collaboration, co-development, clinical trial, consulting, data use, supply, and other agreements. Develop and deliver training to COMPASS departments regarding assigned areas.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

MARCH 1, 2022

Draft, review, and evaluate complex commercial, corporate, and intellectual property transactions, including license, collaboration, co-development, clinical trial, consulting, data use, supply, and other agreements. Develop and deliver training to COMPASS departments regarding assigned areas.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Draft, review, and evaluate complex commercial, corporate, and intellectual property transactions, including license, collaboration, co-development, clinical trial, consulting, data use, supply, and other agreements. Develop and deliver training to COMPASS departments regarding assigned areas.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JANUARY 18, 2019

14, 2019 /PRNewswire/ — The world’s top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25. Cannabis is part and parcel of the next wave of globalization and a serious discussion in Davos could not be more timely,” said iCAN’s Saul Kaye.

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

DECEMBER 7, 2021

“Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. This white paper offers a primer to the complex and confusing global cannabis industry as it stands today.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. Later that night, everyone celebrated at a hotel bar.

DEA 227

DEA Research and Development Clinical Trials Patients 227